Table 1 Clinical information on the patient cohort

Oligo²

Oligodendroglioma, grade 2

3 (X and Z: 10 mm; Y: 20 mm)

LR with 3% Dextran 40

Awake

Oligo³1

Oligodendroglioma, grade 3

3 (X and Y: 20 mm; Z: 10 mm)

LR with 3% Dextran 40

Awake

Oligo³2

Oligodendroglioma, grade 3

3 (X–Z: 10 mm)

aCSF with 3% Dextran 500

Asleep

Oligo³3

Oligodendroglioma, grade 3

3 (X–Z: 10 mm)

3% Albumin A in Plasmalyte-A

Asleep

GemAstro³-mut

Gemistocytic astrocytoma, IDH-mutant, grade 3

3 (X–Z: 10 mm)

3% Albumin A in Plasmalyte-A

Asleep

Astro^4−mut1

Astrocytoma, IDH-mutant, grade 4

3 (X–Z: 10 mm)

LR with 3% Dextran 40

Asleep

Astro^4−mut2

Astrocytoma, IDH-mutant, grade 4

3 (X–Z: 10 mm)

3% Albumin A in Plasmalyte-A

Awake

Astro^4−mut3

Astrocytoma, IDH-mutant, grade 4

3 (X–Z: 10 mm)

aCSF with 3% Dextran 500

Asleep

H3K27M-Astro^4−WT

H3K27M-mutated astrocytoma, IDH-wild type, grade 4

3 (X–Z: 10 mm)

aCSF with 3% Dextran 500

Asleep

GBM^WT1

Glioblastoma

3 (X–Z: 20 mm)

LR with 3% Dextran 40

Awake

GBM^WT2/2B

Glioblastoma

(2B: repeat surgery)

3/2 (X–Z: 10 mm/ X, Z: 10 mm)

aCSF with 3% Dextran 500

Awake

GBM^WT3

Glioblastoma

3 (X–Z: 10 mm)

aCSF with 3% Dextran 500

Asleep

GBM^WT4

Glioblastoma

3 (X–Z: 10 mm)

aCSF with 3% Dextran 500

Asleep

MolecGBM^WT

Molecular glioblastoma

3 (X–Z: 10 mm)

aCSF with 3% Dextran 500

Asleep